First experiences with the stable prostacyclin analog iloprost in the evaluation of heart transplant candidates with increased pulmonary vascular resistance.
Sablotzki
Armin
A
Clinic of Cardiothoracic Surgery, Martin-Luther-University Halle/Wittenberg, Halle/Salle, Germany. sablotzki@aol.com
Czeslick
Elke
E
Gruenig
Ekkehard
E
Friedrich
Ivar
I
Schubert
Susann
S
Börgermann
Jochen
J
Hentschel
Thomas
T
D000280:Administration, Inhalation; D000336:Aerosols; D011464:Epoprostenol / Q000031:analogs & derivatives*; D016027:Heart Transplantation / Q000009:adverse effects*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology*; D016285:Iloprost / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009569:Nitric Oxide / Q000008:administration & dosage*; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000008:administration & dosage*
D000336:Aerosols; D014665:Vasodilator Agents; D009569:Nitric Oxide; D011464:Epoprostenol; D016285:Iloprost